DENTAID Oral Health

News for pharmacy professionals

Back to home page

PERIODONTAL DISEASE EXPLAINED FOR THE PHARMACIST

Learn more

11 Apr 2019

Periodontal disease, aka gum disease, is a set of chronic infectious diseases that affect the periodontium, causing inflammation and/or subsequent destruction. 

The periodontium is the body of tissues that holds and protects the teeth. It is composed of the following tissues: 

Gingiva (gum): the fibromucous membrane that surrounds, protects and helps support the teeth. 

Periodontal ligament: connective tissue fibres that connect the cementum of the tooth to the bone, and which allow for certain, imperceptible tooth mobility. 

Cementum: the protection for the tooth at the root, and the point of the tooth where the connective tissue fibres of the periodontal ligament are inserted. 

Alveolar bone: this houses the teeth. Its presence depends on the existence of the tooth, ie. if the tooth is lost, the alveolar bone will be reabsorbed. 

Periodontal disease is essentially classified as either gingivitis or periodontitis. 

According to the 2016 study by Carasol et al. the prevalence in Spain of these pathologies in the adult working population is 56% for gingivitis, and 38% for periodontitis. That is to say, according to the study, only 6% of the adult Spanish working population has healthy gums

In the vast majority of cases, the origin of periodontal disease lies in the build-up of bacterial plaque, or biofilm, on the teeth, especially in the interdental area or in the margin between the gum and the tooth. This accumulation of bacterial plaque causes a local inflammatory response in the gums: gingivitis. 

GINGIVITIS 

Gingivitis is an infectious disease—originating in most cases from bacterial plaque—causing inflammation, reddening and bleeding of the gums, without there being destruction of the tooth’s supporting tissues. 

Bleeding of the gums is not normal and is a sign of gingivitis. 

There are certain groups at risk of suffering from gingivitis: 

- Brace wearers
- Those experiencing hormonal alterations, in pregnancy, menopause, etc.
- Those who suffer from certain systemic diseases, such as diabetes
- Those under stress
- Those undergoing treatment with certain medicines, such as phenytoin, cyclosporin, or nifedipine. 

Gingivitis is a reversible pathology. That is to say, if the causal factor is eliminated—normally bacterial plaque—the health of the gums can be restored. 

To do so, it is necessary to optimise oral hygiene. The use of specific gum-care formulations is recommended, as well as paying special attention to daily interdental hygiene. Gum health should be monitored in the dental clinic, and prophylaxes should be carried out to remove the dental calculus—popularly known as tartar—which is the bacterial plaque that has hardened and cannot be removed through regular oral hygiene. 

If left untreated and there is genetic predisposition, gingivitis may over time evolve into periodontitis, the destructive form of periodontal disease. 

PERIODONTITIS 

Periodontitis is a chronic infectious disease caused by the build-up of bacterial plaque beneath the gums, causing inflammation and the subsequent destruction of periodontal tissues, i.e. periodontal ligament and bone. 

In addition to inflammation and bleeding, the main signs are gingival recession—in which the gum recedes, and teeth seem “longer”—tooth mobility, bone loss, and eventually potential loss of teeth, which are a consequence of the destruction of the connective tissue, the periodontal ligament and the alveolar bone. 

The step from gingivitis to periodontitis is usually due to the evolution of bacterial plaque to more aggressive species of periodontal pathogens, with the consequent inflammatory response, as well as the concurrence of other risk factors. 

It should be taken into account that genetic predisposition is necessary to develop periodontitis; that is, there are some people who can have gingivitis all their lives without it ever evolving into periodontitis. 

There are additional risk factors for periodontitis, in addition to genetics, among which are: 

- Tobacco smoking: Tobacco smokers are between 5 and 20 times more likely to develop periodontitis. Tobacco smoking accelerates periodontal destruction and masks the signs of the disease, so that it can progress without the patient realising. 

- Diabetes: diabetes and periodontal disease have a two-way relationship. Diabetics are up to 4 times more likely to develop periodontitis. Likewise, individuals with advanced periodontitis are 3.5 times more likely to develop diabetes and its serious complications. 

- Osteoporosis and/or stress: these accelerate periodontal destruction and hinder tissue repair. 

In addition to the harmful consequences for oral health that periodontitis presents, such as tooth loss, it may also have a systemic impact. In fact, there is scientific evidence of the relationship between periodontitis and more than 50 systemic pathologies, such as diabetes, atherosclerotic cardiovascular diseases, pregnancy disorders, rheumatoid arthritis, erectile dysfunction and serious respiratory diseases such as bacterial pneumonia, chronic obstructive pulmonary disease, etc. 

Unlike gingivitis, periodontitis is irreversible, since the tissue destroyed does not recover naturally and would only be possible with surgical regeneration or grafting techniques. It is of vital importance for patients with periodontitis to have the pathology treated as soon as possible, preventing further tissue loss, and keeping their teeth. 

The treatment of periodontitis is performed at the dental clinic and consists mainly of the “mechanical” removal of bacterial plaque and calculus from the teeth, especially at the root. 

Occasionally and by decision of the periodontist—a dentist specialising in periodontal care—surgery may be indicated. The objective of periodontal surgery is usually the treatment of deep periodontal pockets—the spaces that form between the gum and the tooth where the bacteria responsible for periodontal destruction are located—although it may have other intentions such as periodontal tissue regeneration. 

These “mechanical” forms of treatment must be combined with antiseptic treatment. In general, the most commonly recommended is the most powerful antiseptic for the oral cavity: chlorhexidine. The goal is to prevent the growth and development of bacterial plaque, thus preventing disease recurrence. The patient must also improve oral hygiene, with a special focus on interproximal cleaning. 

RELATED ARTICLES

Learn more

18 Nov 2021

Laboratory studies prove that CPC in mouthwashes is effective against different variants of SARS-CoV-2 thanks to its mechanism of action

INTRODUCTION The oral cavity is a route of entry, infection and transmission of microorganisms, including the SARS-CoV-2 coronavirus. Several…

See more
Learn more

15 Jan 2019

ORAL HEALTH IN ADULTS OVER AGE FIFTY

As the years go by, the mouth undergoes both anatomical and physiological changes. These changes, together with poor oral hygiene and certain…

See more
Learn more

02 Oct 2017

CHILDREN’S ORAL HEALTH: BECAUSE EACH AGE REQUIRES SPECIFIC CARE

To maintain good oral health during childhood and to prevent the onset of tooth decay - the most common oral pathology at this age - it is vital that…

See more

Sign up for the DENTAID Oral Health newsletter

Sign up for the newsletter

Data controller DENTAID, S.L. LABORATORIOS DE PREVENCIÓN E HIGIENE BUCAL, SLU (“PHB”).
Purpose of data processing To respond to a query from the interested party with the advice of a specialist.
Legitimisation of data processing Your consent to process your personal data.
Recipients of disclosure or transfer Data is not disclosed or transferred internationally.
Rights of the interested persons To access, rectify and delete their data, and to exercise other rights as set out in the additional information.
Additional information You can consult additional and detailed information on data protection at this link.

Do you want to keep up with the latest news for pharmacy professionals?

Sign up for the DENTAID Oral Health newsletter

Data controller DENTAID, S.L. LABORATORIOS DE PREVENCIÓN E HIGIENE BUCAL, SLU (“PHB”).
Purpose of data processing To respond to a query from the interested party with the advice of a specialist.
Legitimisation of data processing Your consent to process your personal data.
Recipients of disclosure or transfer Data is not disclosed or transferred internationally.
Rights of the interested persons To access, rectify and delete their data, and to exercise other rights as set out in the additional information.
Additional information You can consult additional and detailed information on data protection at this link.

Do you want to keep up with the latest news for pharmacy professionals?

Sign up for the DENTAID Oral Health newsletter

Data controller DENTAID, S.L. LABORATORIOS DE PREVENCIÓN E HIGIENE BUCAL, SLU (“PHB”).
Purpose of data processing To respond to a query from the interested party with the advice of a specialist.
Legitimisation of data processing Your consent to process your personal data.
Recipients of disclosure or transfer Data is not disclosed or transferred internationally.
Rights of the interested persons To access, rectify and delete their data, and to exercise other rights as set out in the additional information.
Additional information You can consult additional and detailed information on data protection at this link.
DENTAID Global

Discover what we are doing worldwide:

DENTAID by countries

Find the latest DENTAID innovations and solutions in each country:

Cookies Policy

Cookies settings have been saved / updated correctly with the indicated preferences.

Close